chr3-191328981-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_198152.5(UTS2B):c.-664-272C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.174 in 152,162 control chromosomes in the GnomAD database, including 2,890 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2888 hom., cov: 32)
Exomes 𝑓: 0.22 ( 2 hom. )
Consequence
UTS2B
NM_198152.5 intron
NM_198152.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.47
Genes affected
UTS2B (HGNC:30894): (urotensin 2B) Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-191328981-G-A is Benign according to our data. Variant chr3-191328981-G-A is described in ClinVar as [Benign]. Clinvar id is 1276371.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.233 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UTS2B | NM_198152.5 | c.-664-272C>T | intron_variant | ENST00000340524.10 | |||
UTS2B | XM_011512631.3 | c.-438C>T | 5_prime_UTR_variant | 1/8 | |||
UTS2B | XM_017006091.2 | c.-438C>T | 5_prime_UTR_variant | 1/8 | |||
UTS2B | XM_047447899.1 | c.-260-272C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UTS2B | ENST00000340524.10 | c.-664-272C>T | intron_variant | 2 | NM_198152.5 | P1 | |||
UTS2B | ENST00000432514.5 | c.-831-272C>T | intron_variant | 5 | |||||
UTS2B | ENST00000464814.1 | n.332C>T | non_coding_transcript_exon_variant | 1/2 | 5 | ||||
UTS2B | ENST00000490825.1 | n.240-9C>T | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.174 AC: 26425AN: 151984Hom.: 2887 Cov.: 32
GnomAD3 genomes
AF:
AC:
26425
AN:
151984
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.217 AC: 13AN: 60Hom.: 2 Cov.: 0 AF XY: 0.143 AC XY: 6AN XY: 42
GnomAD4 exome
AF:
AC:
13
AN:
60
Hom.:
Cov.:
0
AF XY:
AC XY:
6
AN XY:
42
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.174 AC: 26438AN: 152102Hom.: 2888 Cov.: 32 AF XY: 0.173 AC XY: 12893AN XY: 74354
GnomAD4 genome
AF:
AC:
26438
AN:
152102
Hom.:
Cov.:
32
AF XY:
AC XY:
12893
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
214
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 07, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at